Clinical Study of Anlotinib With Temozolomide for Patients With Recurrent Glioblastoma
Latest Information Update: 05 Feb 2020
At a glance
- Drugs Catequentinib (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
Most Recent Events
- 05 Feb 2020 New trial record